Prospect Capital Corporation
NASDAQ:PSECAsset Management
+$0.03 today
- Market cap
- $707.38M
- Beta
- 0.77
- P/E (TTM)
- -28.6
- EPS (TTM)
- -$0.08
- Dividend yield
- 23.77%
Volume 10.96M
Average 5.39M
PSEC Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Prospect Capital CorporationNASDAQ: PSEC
Cash & Equivalents · Q3 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 33.7% from a year ago
Cash & equivalents stood at $34.59M at the end of Q3 FY2026, down 33.7% from a year earlier and up 0.3% from the prior quarter. Over 3 fiscal years it compounded at +14.3% a year.
Context
- Cash & equivalents amounted to 0.5% of total assets at the end of Q3 FY2026, down 0.2 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -33.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 46.51M USD
- Year-over-year change
- -43.2%
- 4-year CAGR
- -7.5%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 46.51M | -43.2% |
| FY2024 | 2024-06-30 | 81.9M | -9.6% |
| FY2023 | 2023-06-30 | 90.57M | +190.6% |
| FY2022 | 2022-06-30 | 31.17M | -51.0% |
| FY2021 | 2021-06-30 | 63.61M | — |
Cash & Equivalents vs competitors
How PSEC compares with its peers on the latest reported figures
- PSEC's Mar 2026 cash & equivalents of $34.59M is the 7th highest of the 11 companies compared; the peer median is $46.49M.
- Its year-over-year change of -33.7% is the 7th highest of 10, against a peer median of -20.3%.
- Cash & equivalents amounts to 0.5% of total assets for PSEC, versus a peer median of 1.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $29.18B | +640330.2% | -34.0% | 0.9% | |
| Mar 2026 | $121.87M | +9.4% | +33.6% | 4.4% | |
| Sep 2026 | $102M | -34.2% | -10.3% | 0.9% | |
| Jun 2026 | $58.31M | -33.0% | -5.1% | 1.0% | |
| Mar 2026 | $51.13M | -40.2% | +4.3% | 2.1% | |
| Mar 2026 | $41.85M | -49.4% | +2.9% | 1.3% | |
| Mar 2026 | $34.59M | -33.7% | +14.3% | 0.5% | |
| Mar 2026 | $30.57M | -20.3% | -0.5% | 1.2% | |
| Mar 2026 | $29.45M | -18.2% | +10.9% | 1.4% | |
| Mar 2026 | $9.25M | +19.8% | -53.8% | 0.5% | |
| Feb 2026 | $3.26M | — | -39.2% | 1.0% | |
| Peer median (excluding PSEC) | $46.49M | -20.3% | -2.8% | 1.1% | |
Competitors are the stored peer set for PSEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Prospect Capital Corporation
NASDAQ:PSEC
Intrinsic Alpha fair value
Locked
Current Price
$1.27
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.